Stock Events

Stock Events

Scorpius

$0.001200

89

+$0.00+9.09% Thursday 14:46

Statistics

Day High

0.0011

Day Low

0.0011

52W High

0.1

52W Low

0.0002

Volume

-

Avg. Volume

-

Mkt Cap

73,371.6

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

27MayExpected

Q1 2024

Q2 2024

Q3 2024

Q1 2025

Q2 2025

Q4 2025

Q1 2026

-32

-5.54

20.91

47.37

Expected EPS

N/A

Actual EPS

N/A

Financials

-525.52%Profit Margin

Unprofitable

2019

2020

2021

2022

2023

2024

12.49MRevenue

-65.62MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SCPX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Moderna is a leader in mRNA technology, directly competing with Nighthawk Biosciences in the development of innovative vaccines and therapies.

BioNTech competes in the mRNA space, similar to Nighthawk Biosciences, focusing on personalized immunotherapies and vaccines.

Novavax is a competitor in the vaccine development space, particularly for infectious diseases, which aligns with Nighthawk Biosciences' focus areas.

Pfizer is a large pharmaceutical company with a broad portfolio that includes vaccines and biopharmaceuticals, competing across several of Nighthawk Biosciences' interest areas.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development of vaccines and therapeutics, overlapping with Nighthawk Biosciences' research and development.

Gilead Sciences

Gilead Sciences is involved in the development of antiviral drugs, directly competing with Nighthawk Biosciences in the area of infectious disease treatment.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals competes in the biotechnology space, focusing on monoclonal antibodies, a technology that could be in direct competition with Nighthawk Biosciences' therapeutic approaches.

Vertex Pharmaceuticals

Vertex Pharmaceuticals is involved in creating novel therapies for treating serious diseases, potentially competing with Nighthawk Biosciences in the biotech innovation space.

Amgen is a biotechnology company focused on human therapeutics, competing with Nighthawk Biosciences in the development of treatments for various diseases.

AstraZeneca is a global, science-led biopharmaceutical business that competes with Nighthawk Biosciences in areas such as oncology, cardiovascular, renal & metabolism, and respiratory diseases.

About

Operating as an integrated contract development and manufacturing organization (CDMO), Scorpius Holdings Inc. primarily conducts its business through its subsidiary, Scorpius BioManufacturing. The company offers a comprehensive array of services to pharmaceutical and biotechnology enterprises, spanning analytical testing, downstream process development, formulation optimization, and clinical biomanufacturing. Additionally, Scorpius Holdings supports clients with pre-clinical and product development, provides analytical assistance for Chemistry, Manufacturing, and Control (CMC), and performs various bioassays. Established in Morrisville, North Carolina, and incorporated in 2008, the company adopted its current name in February 2024, having previously been known as NightHawk Biosciences, Inc.

Show more...

CEO

Mr. Jeffrey Alan Wolf J.D.

Employees

90

Country

United States

ISIN

US42237K5083

Listings

0 Comments

Share your thoughts

FAQ

What is Scorpius stock price today?▼

The current price of SCPX is $0.00 USD — it has increased by +9.09% in the past 24 hours. Watch Scorpius stock price performance more closely on the chart.

What is Scorpius stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Scorpius stocks are traded under the ticker SCPX.

Is Scorpius stock price growing?▼

SCPX stock has risen by +0% compared to the previous week, the month change is a +10% rise, over the last year Scorpius has showed a -97.42% decrease.

What is Scorpius market cap?▼

Today Scorpius has the market capitalization of 73,371.6

What is Scorpius revenue for the last year?▼

Scorpius revenue for the last year amounts to 12.49M USD.

What is Scorpius net income for the last year?▼

SCPX net income for the last year is -65.62M USD.

How many employees does Scorpius have?▼

As of June 20, 2026, the company has 90 employees.

In which sector is Scorpius located?▼

Scorpius operates in the Health & Wellness sector.

When did Scorpius complete a stock split?▼

The last stock split for Scorpius was on July 18, 2024 with a ratio of 1:200.

Where is Scorpius headquartered?▼

Scorpius is headquartered in San Antonio, United States.